Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short-term Mazdutide Plus Lifestyle Intervention Versus Placebo for Pre-hepatectomy Prehabilitation in Living Liver Donors With MASLD: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial

NCT07718126 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT07718126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07718126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short-term Mazdutide Plus Lifestyle Intervention Versus Placebo for Pre-hepatectomy Prehabilitation in Living Liver Donors With MASLD: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
Lead sponsor
West China Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
September 1, 2026
Completion date
August 31, 2029
Enrollment
60 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic steatosis, living liver donors, metabolic dysfunction-associated steatohepatitis